will tirzepatide no longer be available when compounded Not all GLP-1s are created equal., With the rise in popularity of weight loss medications, many people are turning to "off-brand" or compounded alternatives FDA declares Mounjaro, Zepbound shortage
Description
No, you should not use tirzepatide if it appears pink
A handful of glucagon-like peptide-1 (GLP-1) agonists have received US Food and Drug Administration (FDA) approval for obesity treatmentincluding liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound)while others, like exenatide (Byetta, Bydureon), liraglutide (Victoza), semaglutide (Ozempic, Rybelsus), and tirzepatide (again, known as Mounjaro for the diabetes indication), are indicated for type 2 diabetes

These injections are administered once a week and work by regulating appetite and promoting a sense of fullness
Common side effects of semaglutide include nausea, stomach pain, and diarrhea

The theory is that this combination improves adherence, reduces regain risk, and justifies a higher willingness to pay